SGP Holdings

SGP BioSciences is a biotechnology company focused on the discovery and development of a novel class of therapeutics known as Small Giant Proteins (SGPs). These proteins are designed to target traditionally undruggable or challenging membrane proteins, such as ion channels and G protein-coupled receptors (GPCRs), with high specificity and potency. By leveraging its proprietary platform, the company aims to address significant unmet needs in therapeutic areas including chronic pain and neurological disorders. SGP BioSciences utilizes advanced protein engineering to create stable, bioactive molecules that combine the advantages of small molecules and large biologics.